Sunobinop

N/A

Report date: 2024/08/06 09:46:46
NME

Base Information

Drug NameSunobinop
Drug Alias NameSunobinop tosylateV-117957S-117957IMB-115IT-1315 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonists
TargetsNociceptin receptor
Therapy Area/IndicationsAlcoholismUrinary Bladder, OveractiveCystitis, Interstitial +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomania
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPurdue PharmaShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImbrium Therapeutics LpPurdue Pharma Lp
Inactive CompaniesN/A
Active IndicationsAlcoholismUrinary Bladder, OveractiveCystitis, Interstitial +[4] 
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A